| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 63.69M | — |
| Operating expense | — | — |
| Net income | 48.51M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, LGDN.F returned +81.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +46.3% |
| 1 year | +81.8% |
| 5 years | +234.1% |
| 10 years | +309.5% |
| All-time high | €268.00 (Jun 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in LGDN.F would be worth today ›No. Ligand Pharmaceuticals Incorporated has not paid a dividend in the past 12 months.
Ligand Pharmaceuticals Incorporated is part of the Healthcare sector.
Ligand Pharmaceuticals Incorporated has a market cap of 4.78B EUR, based on the latest quote.
Ligand Pharmaceuticals Incorporated is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
